Bortezomib/Daratumumab/Melphalan/Prednisone Regimen

Preferred Label : Bortezomib/Daratumumab/Melphalan/Prednisone Regimen;

NCIt synonyms : Darzalex-VMP Regimen; Bortezomib/Melphalan/Prednisone/Daratumumab; VMP Regimen Plus Daratumumab; Bortezomib-Daratumumab-Melphalan-Prednisone; Bortezomib-Daratumumab-Melphalan-Prednisone Regimen; Bortezomib/Daratumumab/Melphalan/Prednisone; Bortezomib/Melphalan/Prednisone Plus Daratumumab; Velcade/Melphalan/Prednisone/Darzalex; Darzalex Plus VMP; VMP-Darzalex;

NCIt related terms : Dara-VMP;

NCIt definition : A regimen consisting of bortezomib, daratumumab, melphalan and prednisone that can be used for the treatment of plasma cell (multiple) myeloma.;

NCI Metathesaurus CUI : CL1664469;

Codes from synonyms : 26535;

Détails

Origin ID

C181585;

UMLS CUI

C5557168;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bortezomib [NCIt concept]
- Daratumumab [NCIt concept]
- Melphalan [NCIt concept]
- Prednisone [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients